Filter by Category: SENTRY Surveillance

Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp. and Aspergillus spp.: Results from the Global SENTRY Antimicrobial Surveillance Program (2008).

Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp. and Aspergillus spp.: Results from the Global SENTRY Antimicrobial Surveillance Program (2008). by Messer SA, Jones RN, Moet GJ, Kirby JT and Castanheira M published in J. Clin. Microbiol. 2010; 48 (8): 2984-2987

First descriptions of blaKPC in Raoultella spp. (R. planticola and R. ornithinolytica): Report from the SENTRY Antimicrobial Surveillance Program.

First descriptions of blaKPC in Raoultella spp. (R. planticola and R. ornithinolytica): Report from the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Deshpande LM, DiPersio JR, Kang J, Weinstein MP and Jones RN published in J. Clin. Microb. 2009; 47 (12); 4129-4130

Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using Clinical and Laboratory Standards Institute methods: a SENTRY Antimicrobial Surveillance Program report.

Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using Clinical and Laboratory Standards Institute methods: a SENTRY Antimicrobial Surveillance Program report. by Bell JM, Turnidge JD, Jones RN published in J. Clin. Microb. 2009; 47 (7): 2187-2193

Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus Spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)

Activity of contemporary antifungal agents, including the novel Echinocandin Anidulafungin, tested against Candida spp., Cryptococcus Spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007) by Messer SA, Moet GJ, Kirby JT, and Jones RN published in J. Clin. Microbiol. 2009; 47(6):1942-1946

Dissemination of a blaVIM-2-carrying integron among Enterobacteriaceae species in Mexico: Report from the SENTRY Antimicrobial Surveillance Program.

Dissemination of a blaVIM-2-Carrying Integron Among Enterobacteriaceae species in Mexico: Report from the SENTRY Antimicrobial Surveillance Program. by Morfin-Otero R, Rodriguez-Nkoriega E, Desphande LM, Sader HS, Castanheira M published in Microbial. Drug Resistance. 2009; 15 (1): 33-35

Codetection of blaOXA-23--like gene (blaOXA-133) and blaOXA-58 in Acintobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program.

Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acintobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program. by Mendes RE, Bell JM, Turnidge JD, Castanheira M, Deshpande LM and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (2): 843-844

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemased among Acinetobacter spp. in Asia-Pacific nations: Report from the SENTRY Surveillance Program.

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemased among Acinetobacter spp. in Asia-Pacific nations: Report from the SENTRY Surveillance Program. by Mendes RE, Bell JM, Turnidge JD, Castanheira M, and Jones RN published in J. Antimicrob. Chemother. 2009; 63 (1): 55-59

Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acintobacter baumannii strains in Houston, Texas: Report from the SENTRY Antimicrobial Surveillance Program.

Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acintobacter baumannii strains in Houston, Texas: Report from the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Wanger A, Kruzel M, Deshpande LM and Jones RN published in J. Clin. Microbiol. 2008; 46 (9): 3179-3180

Antimicrobial susceptibility of Gram-negative bacilli isolated in Brazilian hospitals participating in the SENTRY Program (2003-2008).

Antimicrobial susceptibility of Gram-negative bacilli isolated in Brazilian hospitals participating in the SENTRY Program (2003-2008). by Andrade S, Sader HS, Barth A, Ribeiro J, Zoccoli C, Pignatari AC and Gales AC published in Braz. J. Infect. Dis. 2008; 12 (Suppl. 2): S3-S9

Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2005-2006).

Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2005-2006). by Fritsche TR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2008; 61 (1): 86-95